...
首页> 外文期刊>American pharmaceutical review >Analytical Methodology for Characterization of Reactive Starting Materials and Intermediates Commonly Used in the Synthesis of Small Molecule Pharmaceuticals
【24h】

Analytical Methodology for Characterization of Reactive Starting Materials and Intermediates Commonly Used in the Synthesis of Small Molecule Pharmaceuticals

机译:用于表征反应性原料的分析方法和常用于小分子药物的中间体

获取原文
获取原文并翻译 | 示例
           

摘要

This reviewfocuses on the analytical challenges of chromatographically characterizing sulfonate salts/esters, hydrazine functionalities, amines, boronate esters/acids, aldehydes, and sulfonate acid/esters, and acyl (acid) halides used in the synthesis of pharmaceutical drug substances. Special focus is placed on stability, degradation, and achieving the low level sensitivity required for genotoxic impurity analysis. Final pharmaceutical drug substances are designed to be stable to meet shelf life requirements, survive pharmaceutical processing into drug products, and intact delivery through the Gl and/or bloodstream to their sites of action. However, the building blocks of these APIs are not constrained by the same stability requirements and may require special considerations to be accurately analyzed.
机译:该综述关于色谱分析磺酸盐/酯,肼官能团,硼酸酯/酸,醛和磺酸酸/酸的分析挑战,以及用于合成药物药物物质的酰基(酸)卤化物。 特别重点放在稳定性,降解和实现基因毒性杂质分析所需的低水平灵敏度。 最终的药物药物旨在稳定,以满足保质期要求,将药物加工生存到药品中,并通过GL和/或血液完整地递送到其作用部位。 然而,这些API的构建块不受相同的稳定性要求约束,并且可能需要准确地分析特殊考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号